• Treatment of Severe Eye Chemical Burns with Allogeneic Bone Marrow-Derived Mesenchymal Stromal Cells for Patients with Severe Ocular Chemical Burns

    Not yet recruiting

    2 1 1 1
    France
  • A study testing inhaled amikacin compared to placebo in critically ill patients with ventilator-associated tracheobronchitis

    Not yet recruiting

    3 1 1
    Investigated drugs:
    France
  • A study comparing RP2 with nivolumab versus ipilimumab with nivolumab in adults with metastatic uveal melanoma not previously treated with immune checkpoint inhibitors

    Not yet recruiting

    4 1 1 1
    Investigated diseases:
    France Germany Italy Poland Spain
  • Testing inotuzumab ozogamicin and blinatumomab with drug combination for children with relapsed precursor B-cell acute lymphoblastic leukemia

    Not yet recruiting

    3 1 1 1
    Austria Czechia Denmark Finland France Germany +5
  • A Study Testing the Safety of CD19-Targeted CAR T-Cell Therapy in Children and Young Adults with Relapsed or Refractory B-Cell Cancers

    Not yet recruiting

    1 1 1
    Investigated drugs:
    The Netherlands
  • Study of Fecal Microbiota Transplantation Compared to Sham Treatment for Patients with Primary Sclerosing Cholangitis

    Not yet recruiting

    4 1
    Investigated diseases:
    France
  • A study testing dapagliflozin and SC0062 together compared to SC0062 alone in adults with type 1 diabetes and chronic kidney disease

    Not yet recruiting

    2 1 1 1
    Investigated drugs:
    Denmark Finland The Netherlands
  • Testing the safety and effectiveness of stem cells from fat tissue in children with autism spectrum disorder and digestive problems

    Not yet recruiting

    1 1 1
    Investigated diseases:
    Denmark
  • Comparing Dapagliflozin and Tocilizumab for Treating Patients with Systemic Sclerosis

    Not yet recruiting

    2 1 1
    Investigated diseases:
    Poland
  • Comparing morphine alone to morphine and lidocaine for pain relief in sickle cell anemia patients with vaso-occlusive crisis

    Not yet recruiting

    3 1 1 1
    Belgium

powered by